Hims & Hers Health surges on acquisition for at-home testing

Hims & Hers Health ( HIMS ) stock gains on news that the company acquired Trybe Labs, which will allow the telehealth company to offer at-home testing. The deal will create competition for Labcorp ( LH ) and Quest ( DGX )

Julie Hyman and Seana Smith outline what investors need to know.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here .

This post was written by Naomi Buchanan.